A comparably low seeding efficacy of progressive supranuclear palsy and corticobasal degeneration homogenates was found in a cell-based aggregation assay, while seeds of Alzheimer’s disease patients resulted in high tau aggregation (Chung et al., 2019). This evidence concerns the gene MAPT and progressive supranuclear palsy.